by Jason Parker — April 16, 2021
Revibe Technologies will invest in the clinical and regulatory development of its flagship product, Revibe Connect, a digital therapeutic smartwatch device powered by artificial intelligence after closing $3 million in funding led by the Carolina Angel Network. To lead this effort, company founder Rich Brancaccio will transition from the role of CEO to the role of chief innovation officer, and the company will hire Joseph Koziak as its new CEO, it announced in a statement.
The company’s product aims to assist children with autism and attention deficit hyperactivity disorder (ADHD) with maintaining focus, using an algorithm backed by artificial intelligence that sends vibration signals to a user wearing the device.
Koziak’s prior company, Amblyotech, was sold to Novartis in April of 2020. He called joining Revibe Technologies an easy decision in a statement, noting that he plans to lead the team to fulfill the original vision to assist students in achieving academic and personal success.
The company was founded in 2013, and has previously received research funding from the U.S. Department of Education, and its products have been used in school districts in New York City, Denver, and Wake County.
Original Source: WRAL TechWire